Latest News

GE Healthcare Life Sciences and Emerson team up to drive efficiency

GE Healthcare’s Life Sciences business and Emerson Process Management have announced a collaboration aimed at increasing productivity and improving efficiency in the production of biopharmaceuticals such as monoclonal antibodies and vaccines. 

The two companies will collaborate to integrate Emerson’s DeltaV distributed control system with GE Healthcare’s enterprise offerings and start-to-finish technologies for the global bio-manufacturing industry. 

The first DeltaV-driven GE Healthcare installation, which is expected to be complete before the end of the year, will be a FlexFactory, GE’s integrated manufacturing platform based on single-use technologies.   
Biopharmaceutical manufacturers are increasingly looking to automate production processes, driven by the industry need to increase efficiency and reduce costs. GE’s start-to-finish portfolio of single-use bioprocessing technologies already allows manufacturers to reduce set-up times and increase manufacturing flexibility. 

Emerson’s DeltaV system, which uses predictive technologies to connect people, processes and production, enables remote monitoring and control from multiple locations across a company’s network and is already widely used in the pharmaceutical industry. 

The DeltaV system will be offered as an automation control platform for GE’s single-use bioprocessing offerings.

Send this to a friend